Futoshi Kuribayashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Futoshi Kuribayashi has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Akira Yamauchi
Department of Biochemistry, Kawasaki Medical School, Kurashiki, Japan
4 shared publications - Junichiro Futami
Graduate School of Interdisciplinary Science and Engineering in Health Systems Okayama University Okayama Japan
3 shared publications - Masakiyo Sakaguchi
Department of Cell Biology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan
3 shared publications - Eisaku Kondo
Division of Tumor Pathology, Near InfraRed Photo-ImmunoTherapy Research Institute, Kansai Medical University, Hirakata, Japan
2 shared publications - Hitoshi Murata
Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan
2 shared publications - Nahoko Tomonobu
Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
2 shared publications
Latest Publications
- Open Access
- 21 January 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (8) , 1930-1945.e3
An S100A8/A9 Neutralizing Antibody Potently Ameliorates Contact Hypersensitivity and Atopic Dermatitis Symptoms
- 21 January 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (8) , 1930-1945.e3
Open AccessAn S100A8/A9 Neutralizing Antibody Potently Ameliorates Contact Hypersensitivity and Atopic Dermatitis Symptoms
- Open Access
- 26 March 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1371342
Lysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface
Background: Our earlier research revealed that the secreted lysyl oxidase-like 4 (LOXL4) that is highly elevated in triple-negative breast cancer (TNBC) acts as a catalyst to lock annexin A2 on the cell membrane surface, which accelerates invasive outgrowth of the cancer through the binding of integrin-β1 on the cell surface. However, whether this machinery is subject to the LOXL4-mediated intrusive regulation remains uncertain.Methods: Cell invasion was assessed using a transwell-based assay, protein–protein interactions by an immunoprecipitation–Western blotting technique and immunocytochemistry, and plasmin activity in the cell membrane by gelatin zymography.Results: We revealed that cell surface annexin A2 acts as a receptor of plasminogen via interaction with S100A10, a key cell surface annexin A2-binding factor, and S100A11. We found that the cell surface annexin A2/S100A11 complex leads to mature active plasmin from bound plasminogen, which actively stimulates gelatin digestion, followed by increased invasion.Conclusion: We have refined our understanding of the role of LOXL4 in TNBC cell invasion: namely, LOXL4 mediates the upregulation of annexin A2 at the cell surface, the upregulated annexin 2 binds S100A11 and S100A10, and the resulting annexin A2/S100A11 complex acts as a receptor of plasminogen, readily converting it into active-form plasmin and thereby enhancing invasion.
- 26 March 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1371342
Open AccessLysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface
Background: Our earlier research revealed that the secreted lysyl oxidase-like 4 (LOXL4) that is highly elevated in triple-negative breast cancer (TNBC) acts as a catalyst to lock annexin A2 on the cell membrane surface, which accelerates invasive outgrowth of the cancer through the binding of integrin-β1 on the cell surface. However, whether this machinery is subject to the LOXL4-mediated intrusive regulation remains uncertain.Methods: Cell invasion was assessed using a transwell-based assay, protein–protein interactions by an immunoprecipitation–Western blotting technique and immunocytochemistry, and plasmin activity in the cell membrane by gelatin zymography.Results: We revealed that cell surface annexin A2 acts as a receptor of plasminogen via interaction with S100A10, a key cell surface annexin A2-binding factor, and S100A11. We found that the cell surface annexin A2/S100A11 complex leads to mature active plasmin from bound plasminogen, which actively stimulates gelatin digestion, followed by increased invasion.Conclusion: We have refined our understanding of the role of LOXL4 in TNBC cell invasion: namely, LOXL4 mediates the upregulation of annexin A2 at the cell surface, the upregulated annexin 2 binds S100A11 and S100A10, and the resulting annexin A2/S100A11 complex acts as a receptor of plasminogen, readily converting it into active-form plasmin and thereby enhancing invasion.
- Open Access
- 6 October 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 634, 83-91
Toll-like receptor 4 promotes bladder cancer progression upon S100A8/A9 binding, which requires TIRAP-mediated TPL2 activation
- 6 October 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 634, 83-91
Open AccessToll-like receptor 4 promotes bladder cancer progression upon S100A8/A9 binding, which requires TIRAP-mediated TPL2 activation
- Open Access
- 1 March 2021
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 25, 100891
Ellagic acid and its fermentative derivative urolithin A show reverse effects on the gp91-phox gene expression, resulting in opposite alterations in all-trans retinoic acid-induced superoxide generating activity of U937 cells
- 1 March 2021
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 25, 100891
Open AccessEllagic acid and its fermentative derivative urolithin A show reverse effects on the gp91-phox gene expression, resulting in opposite alterations in all-trans retinoic acid-induced superoxide generating activity of U937 cells
- 1 January 1997
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 337 (1) , 75-80
Changes of Energy Metabolism Induced by 1-Methyl-4-phenylpyridinium (MPP+)-Related Compounds in Rat Pheochromocytoma PC12 Cells
- 1 January 1997
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 337 (1) , 75-80
Changes of Energy Metabolism Induced by 1-Methyl-4-phenylpyridinium (MPP+)-Related Compounds in Rat Pheochromocytoma PC12 Cells